Home Cybin

Cybin

In operation
Seasoned Equity Offering
Psychedelic Drug Development and R&D Companies
Basic
Enterprise Profile
LinkedIn

Basic Information

Cybin is a leading biotechnology company focused on advancing psychedelic therapies by leveraging patented drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment solutions for mental health disorders. We are committed to fundamentally transforming the mental healthcare experience for individuals affected by mental health conditions and their loved ones by providing powerful and effective new psychedelic therapies that are accessible to all. We are working to enhance compliance by offering convenient and accessible new psychedelic therapies to all patients seeking treatment for mental health disorders through diverse pathways and practical treatment durations.
Cybin Inc.
Toronto,Ontario,Canada
15~50 people
January 01, 2019
info@cybin.com

Enterprise Profile

Industrial Sector
Compound Design New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
# Nervous System Diseases Therapeutic Products Depression
Application Scenarios
Chemical Drug Innovative Drugs